These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 9359838

  • 1. Inositol 1,4,5-trisphosphate receptor subtypes differentially recognize regioisomers of D-myo-inositol 1,4,5-trisphosphate.
    Hirata M, Takeuchi H, Riley AM, Mills SJ, Watanabe Y, Potter BV.
    Biochem J; 1997 Nov 15; 328 ( Pt 1)(Pt 1):93-8. PubMed ID: 9359838
    [Abstract] [Full Text] [Related]

  • 2. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT, Bullock AJ, Lindley CJ, Mills SJ, Riley AM, Potter BV, Westwick J.
    Mol Pharmacol; 1996 Nov 15; 50(5):1223-30. PubMed ID: 8913354
    [Abstract] [Full Text] [Related]

  • 3. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
    Wilcox RA, Erneux C, Primrose WU, Gigg R, Nahorski SR.
    Mol Pharmacol; 1995 Jun 15; 47(6):1204-11. PubMed ID: 7603461
    [Abstract] [Full Text] [Related]

  • 4. Inositol-1,3,4,5-tetrakisphosphate induces calcium mobilization via the inositol-1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells.
    Wilcox RA, Challiss RA, Liu C, Potter BV, Nahorski SR.
    Mol Pharmacol; 1993 Oct 15; 44(4):810-7. PubMed ID: 8232232
    [Abstract] [Full Text] [Related]

  • 5. Conformational changes in plant Ins(1,4,5)P3 receptor on interaction with different myo-inositol trisphosphates and its effect on Ca2+ release from microsomal fraction and liposomes.
    Dasgupta S, Dasgupta D, Chatterjee A, Biswas S, Biswas BB.
    Biochem J; 1997 Jan 15; 321 ( Pt 2)(Pt 2):355-60. PubMed ID: 9020866
    [Abstract] [Full Text] [Related]

  • 6. Two calcium-binding sites mediate the interconversion of liver inositol 1,4,5-trisphosphate receptors between three conformational states.
    Marshall IC, Taylor CW.
    Biochem J; 1994 Jul 15; 301 ( Pt 2)(Pt 2):591-8. PubMed ID: 8043006
    [Abstract] [Full Text] [Related]

  • 7. Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA, Challiss RA, Traynor JR, Fauq AH, Ognayanov VI, Kozikowski AP, Nahorski SR.
    J Biol Chem; 1994 Oct 28; 269(43):26815-21. PubMed ID: 7929418
    [Abstract] [Full Text] [Related]

  • 8. Binding and activity of the nine possible regioisomers of myo-inositol tetrakisphosphate at the inositol 1,4,5-trisphosphate receptor.
    Burford NT, Nahorski SR, Chung SK, Chang YT, Wilcox RA.
    Cell Calcium; 1997 Apr 28; 21(4):301-10. PubMed ID: 9160166
    [Abstract] [Full Text] [Related]

  • 9. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: recognition by cerebellar and platelet inositol-1,4,5-trisphosphate receptors.
    Murphy CT, Riley AM, Lindley CJ, Jenkins DJ, Westwick J, Potter BV.
    Mol Pharmacol; 1997 Oct 28; 52(4):741-8. PubMed ID: 9380038
    [Abstract] [Full Text] [Related]

  • 10. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA, Fauq A, Kozikowski AP, Nahorski SR.
    FEBS Lett; 1997 Feb 03; 402(2-3):241-5. PubMed ID: 9037203
    [Abstract] [Full Text] [Related]

  • 11. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
    Hirata M, Narumoto N, Watanabe Y, Kanematsu T, Koga T, Ozaki S.
    Mol Pharmacol; 1994 Feb 03; 45(2):271-6. PubMed ID: 8114676
    [Abstract] [Full Text] [Related]

  • 12. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
    Safrany ST, Wojcikiewicz RJ, Strupish J, Nahorski SR, Dubreuil D, Cleophax J, Gero SD, Potter BV.
    FEBS Lett; 1991 Jan 28; 278(2):252-6. PubMed ID: 1846823
    [Abstract] [Full Text] [Related]

  • 13. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
    Safrany ST, Wilcox RA, Liu C, Dubreuil D, Potter BV, Nahorski SR.
    Mol Pharmacol; 1993 Apr 28; 43(4):499-503. PubMed ID: 8386304
    [Abstract] [Full Text] [Related]

  • 14. Myo-inositol 1,3,4,5-tetrakisphosphate can independently mobilise intracellular calcium, via the inositol 1,4,5-trisphosphate receptor: studies with myo-inositol 1,4,5-trisphosphate-3-phosphorothioate and myo-inositol hexakisphosphate.
    Wilcox RA, Whitham EM, Liu C, Potter BV, Nahorski SR.
    FEBS Lett; 1993 Dec 27; 336(2):267-71. PubMed ID: 8262243
    [Abstract] [Full Text] [Related]

  • 15. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities.
    Wilcox RA, Safrany ST, Lampe D, Mills SJ, Nahorski SR, Potter BV.
    Eur J Biochem; 1994 Jul 01; 223(1):115-24. PubMed ID: 8033885
    [Abstract] [Full Text] [Related]

  • 16. Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,4,5-trisphosphate receptors.
    Marchant JS, Beecroft MD, Riley AM, Jenkins DJ, Marwood RD, Taylor CW, Potter BV.
    Biochemistry; 1997 Oct 21; 36(42):12780-90. PubMed ID: 9335535
    [Abstract] [Full Text] [Related]

  • 17. Roles for hydroxyl groups of D-myo-inositol 1,4,5-trisphosphate in the recognition by its receptor and metabolic enzymes.
    Hirata M, Watanabe Y, Yoshida M, Koga T, Ozaki S.
    J Biol Chem; 1993 Sep 15; 268(26):19260-6. PubMed ID: 8396130
    [Abstract] [Full Text] [Related]

  • 18. Regulation of phosphatidylinositide transduction system in the rat spinal cord during aging.
    Igwe OJ, Filla MB.
    Neuroscience; 1995 Dec 15; 69(4):1239-51. PubMed ID: 8848110
    [Abstract] [Full Text] [Related]

  • 19. Inositol trisphosphate analogues selective for types I and II inositol trisphosphate receptors exert differential effects on vasopressin-stimulated Ca2+ inflow and Ca2+ release from intracellular stores in rat hepatocytes.
    Gregory RB, Hughes R, Riley AM, Potter BV, Wilcox RA, Barritt GJ.
    Biochem J; 2004 Jul 15; 381(Pt 2):519-26. PubMed ID: 15169542
    [Abstract] [Full Text] [Related]

  • 20. Acyclophostin: a ribose-modified analog of adenophostin A with high affinity for inositol 1,4,5-trisphosphate receptors and pH-dependent efficacy.
    Beecroft MD, Marchant JS, Riley AM, Van Straten NC, Van der Marel GA, Van Boom JH, Potter BV, Taylor CW.
    Mol Pharmacol; 1999 Jan 15; 55(1):109-17. PubMed ID: 9882704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.